These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 15747035)

  • 1. The influence of 4-week treatment with sertraline on the combined T3/TRH test in depressed patients.
    Schüle C; Baghai TC; Alajbegovic L; Schwarz M; Zwanzger P; Eser D; Schaaf L; Möller HJ; Rupprecht R
    Eur Arch Psychiatry Clin Neurosci; 2005 Oct; 255(5):334-40. PubMed ID: 15747035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The combined T3/TRH test in depressed patients and healthy controls.
    Schüle C; Baghai TC; Tsikolata V; Zwanzger P; Eser D; Schaaf L; Rupprecht R
    Psychoneuroendocrinology; 2005 May; 30(4):341-56. PubMed ID: 15694114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronobiological hypothalamic-pituitary-thyroid axis status and antidepressant outcome in major depression.
    Duval F; Mokrani MC; Erb A; Gonzalez Lopera F; Alexa C; Proudnikova X; Butucaru I
    Psychoneuroendocrinology; 2015 Sep; 59():71-80. PubMed ID: 26036452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum thyrotropin and prolactin in the syndrome of generalized resistance to thyroid hormone: responses to thyrotropin-releasing hormone stimulation and short term triiodothyronine suppression.
    Sarne DH; Sobieszczyk S; Ain KB; Refetoff S
    J Clin Endocrinol Metab; 1990 May; 70(5):1305-11. PubMed ID: 2110573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between chronobiological thyrotropin and prolactin responses to protirelin (TRH) and suicidal behavior in depressed patients.
    Duval F; Mokrani MC; Erb A; Gonzalez Opera F; Calleja C; Paris V
    Psychoneuroendocrinology; 2017 Nov; 85():100-109. PubMed ID: 28843902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of antidepressant treatment on thyrotropin-releasing hormone stimulation, growth hormone response to L-DOPA, and dexamethasone suppression tests in major depressive patients.
    Esel E; Kartalci S; Tutus A; Turan T; Sofuoglu S
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar; 28(2):303-9. PubMed ID: 14751427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T3 augmentation of SSRI resistant depression.
    Abraham G; Milev R; Stuart Lawson J
    J Affect Disord; 2006 Apr; 91(2-3):211-5. PubMed ID: 16483669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary evidence that a functional polymorphism in type 1 deiodinase is associated with enhanced potentiation of the antidepressant effect of sertraline by triiodothyronine.
    Cooper-Kazaz R; van der Deure WM; Medici M; Visser TJ; Alkelai A; Glaser B; Peeters RP; Lerer B
    J Affect Disord; 2009 Jul; 116(1-2):113-6. PubMed ID: 19064291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained rises in serum thyrotropin, thyroxine, and triiodothyronine during long term, continuous thyrotropin-releasing hormone treatment in patients with amyotrophic lateral sclerosis.
    Kaplan MM; Taft JA; Reichlin S; Munsat TL
    J Clin Endocrinol Metab; 1986 Oct; 63(4):808-14. PubMed ID: 3091628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypothalamic-pituitary axis and peripheral tissue responses to TRH stimulation and liothyronine suppression tests in normal subjects evaluated by current methods.
    Dare GL; de Castro M; Maciel LM
    Thyroid; 2008 Apr; 18(4):401-9. PubMed ID: 18399766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid antidepressant response after nocturnal TRH administration in patients with bipolar type I and bipolar type II major depression.
    Szuba MP; Amsterdam JD; Fernando AT; Gary KA; Whybrow PC; Winokur A
    J Clin Psychopharmacol; 2005 Aug; 25(4):325-30. PubMed ID: 16012274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns off recovery of the hypothalamic-pituitary-thyroid axis in patients taken of chronic thyroid therapy.
    Krugman LG; Hershman JM; Chopra IJ; Levine GA; Pekary E; Geffner DL; Chua Teco GN
    J Clin Endocrinol Metab; 1975 Jul; 41(1):70-80. PubMed ID: 807596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assignment of the beta-thyroid hormone receptor to 3,5,3'-triiodothyronine-dependent inhibition of transcription from the thyrotropin-releasing hormone promoter in chick hypothalamic neurons.
    Lezoualc'h F; Hassan AH; Giraud P; Loeffler JP; Lee SL; Demeneix BA
    Mol Endocrinol; 1992 Nov; 6(11):1797-804. PubMed ID: 1480171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of acute increases in serum triiodothyronine on TSH and prolactin responses to TRH, and estimates of pituitary stores of TSH and prolactin in normal subjects and in patients with primary hypothyroidism.
    Wartofsky L; Dimond RC; Noel GL; Frantz AG; Earll JM
    J Clin Endocrinol Metab; 1976 Mar; 42(3):443-58. PubMed ID: 815265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response of the maternal, fetal, and neonatal pituitary-thyroid axis to thyrotropin-releasing hormone.
    Moya F; Mena P; Heusser F; Foradori A; Paiva E; Yazigi R; Michaud P; Gross I
    Pediatr Res; 1986 Oct; 20(10):982-6. PubMed ID: 3095783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined therapy of T3, and antidepressants in depression.
    Tsutsui S; Yamazaki Y; Namba T; Tsushima M
    J Int Med Res; 1979; 7(2):138-46. PubMed ID: 113269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of N3im-methyl-thyrotropin releasing hormone on the human pituitary-thyroid axis.
    Sowers JR; Hershman JM; Pekary AE; Nair MG; Baugh CM
    J Clin Endocrinol Metab; 1976 Oct; 43(4):741-8. PubMed ID: 824296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Maprotiline versus fluvoxamine: comparison of their effects on the hypothalamo-hypophyseal-thyroid axis].
    De Mendonça Lima CA; Vandel S; Bonin B; Bechtel P; Carron R
    Encephale; 1997; 23(1):48-55. PubMed ID: 9172968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addition of risperidone to sertraline improves sertraline-resistant refractory depression without influencing plasma concentrations of sertraline and desmethylsertraline.
    Yoshimura R; Umene-Nakano W; Ueda N; Ikenouchi-Sugita A; Hori H; Nakamura J
    Hum Psychopharmacol; 2008 Dec; 23(8):707-13. PubMed ID: 18803170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.